The DOI matches its Crossref record; 380 of the 385 references it cites were found in a registry or an index.
The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Open accessAbstract
The liver is a dynamic organ that plays critical roles in many physiological processes, including the regulation of systemic glucose and lipid metabolism. Dysfunctional hepatic lipid metabolism is a cause of nonalcoholic fatty liver disease (NAFLD), the most common chronic liver disorder worldwide, and is closely associated with insulin resistance and type 2 diabetes. Through the use of advanced mass spectrometry “omics” approaches and detailed experimentation in cells, mice, and humans, we now understand that the liver secretes a wide array of proteins, metabolites, and noncoding RNAs (miRNAs) and that many of these secreted factors exert powerful effects on metabolic processes both in the liver and in peripheral tissues. In this review, we summarize the rapidly evolving field of “hepatokine” biology with a particular focus on delineating previously unappreciated communication between the liver and other tissues in the body. We describe the NAFLD-induced changes in secretion of liver proteins, lipids, other metabolites, and miRNAs, and how these molecules alter metabolism in liver, muscle, adipose tissue, and pancreas to induce insulin resistance. We also synthesize the limited information that indicates that extracellular vesicles, and in particular exosomes, may be an important mechanism for intertissue communication in normal physiology and in promoting metabolic dysregulation in NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with ~2,500 liver-secreted proteins identified using modern liquid chromatography and mass spectroscopy technologies39.”
From Exerkines in health, resilience and disease (2022) · cites this paper as [39]
In the citing paper
“These exerkines affect glucose and/or lipid metabolism (for example, angiopoietin-like protein 4 in humans and animal models39,79), browning of WAT (FGF21 in a mouse model106), lipolysis (FGF21 in humans and a mouse model77) and the maintenance of cellular homeostasis (heat shock protein 72 in humans107).”
From Exerkines in health, resilience and disease (2022) · cites this paper as [39]
In the citing paper
“fetuin-A worsens peripheral insulin resistance by reducing insulin signalling and glucose transporter type 4 trafficking39.”
From Exerkines in health, resilience and disease (2022) · cites this paper as [39]
In the citing paper
“Activin-E is elevated in the livers and serum of humans with obesity and NAFLD (Table 1) [29]”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [29]
In the citing paper
“Furthermore, knockdown of FST in mice improved insulin sensitivity [29,196].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [29]
In the citing paper
“Hepassocin has also been implicated in skeletal muscle insulin resistance through an AMPK-dependent mechanism [29] (Figure 3).”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [29]
In the citing paper
“These findings coincide with studies in mice that demonstrate increased hepatic expression of SeP in response to high-fat diet feeding, NAFLD, and type 2 diabetes [29,260,265].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
Mammalian microRNAs predominantly act to decrease target mRNA levels
Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886
Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes
Trajković, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brügger, B., & Simons, M. (2008) · Science · doi:10.1126/science.1153124 · Cited by 3,760
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Flagged first, then by citations
5 of the 385 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Berglund, 2009, Fibroblast growth fact or 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity, 4084
Cited by
Sorted by citations
Items 201–300 of 620
Guo, X., Su, Y. B., Du, Y., Zhang, F., Yu, W., Ren, W.-C., Li, S., Kuang, H., & Wu, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.139514 · Cited by 20
The endocrine role of hepatokines: implications for human health and disease
Iglesias, P. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1663353 · Cited by 23
Song, S., Duo, Y., Zhang, Y., Qiao, X., Xu, J., Zhang, J., Peng, Z., Chen, Y., Nie, X., Sun, Q., et al. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s335364 · Cited by 19
Zhao, Z., Zou, J., Huang, X., Fan, Y., & Wang, K. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.971913 · Cited by 21
Mori, K., Tanaka, M., Hosaka, I., Mikami, T., Endo, K., Hanawa, N., Ohnishi, H., & Furuhashi, M. (2023) · Hypertension Research · doi:10.1038/s41440-023-01179-0 · Cited by 19
Li, R., Kong, D., Ye, Z., Zong, G., Hu, K., Xu, W., Fang, P., Zhang, L., Zhou, Y., Zhang, K., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1127134 · Cited by 19
Role of extracellular vesicles in nonalcoholic fatty liver disease
Jiang, W., Xu, Y., Chen, J.-C., Lee, Y.-H., Hu, Y., Liu, C., Chen, E., Tang, H., Zhang, H., & Wu, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1196831 · Cited by 20
N6-methyladenosine RNA modification in nonalcoholic fatty liver disease
Ping, L., Li, S., Wei, J., Tu, J., & Long, X. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.09.002 · Cited by 20
Zhu, Y., Zhang, K.-X., Bu, Q., Song, S., Chen, Y., Zou, H., You, X., & Zhao, G. (2024) · Phytotherapy Research · doi:10.1002/ptr.8402 · Cited by 18
Dias, K. A., Oliveira, L. A., Pereira, S. M. S., Abrantes, L. C. S., Vicente, L. C. O. D. S., Gonçalves, R. V., & Lúcia, C. M. D. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2472882 · Cited by 18
Circulating cathepsin S improves glycaemic control in mice
Karimkhanloo, H., Keenan, S. N., Sun, E. W. L., Wattchow, D. A., Keating, D. J., Montgomery, M. K., & Watt, M. J. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0408 · Cited by 19
Self-citationLiu, W., Zhang, X., Li, G., Tang, L., Zhu, P., Rios, R. S., Zheng, K. I., Ma, H., Wang, X., Pan, Q., et al. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2021.0301 · Cited by 18
Xanthine oxidoreductase activity is correlated with hepatic steatosis
Yagi, C., Kusunoki, Y., Tsunoda, T., Murase, T., Nakamura, T., Osugi, K., Ohigashi, M., Morimoto, A., Miyoshi, A., Kakutani‐Hatayama, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16688-0 · Cited by 18
Zhang, Y., Wang, L., Qi, J., Yu, B., Zhao, J., Pang, L., Zhang, W., & Bin, L. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01012-1 · Cited by 18
Effects of alternate-day fasting and time-restricted feeding in obese middle-aged female rats
Bilibio, B. L. E., REIS, W. R. D., Compagnon, L., de Batista, D. G., Sulzbacher, L. M., Pinheiro, J. F., Ludwig, M. S., Frizzo, M. N., Cruzat, V. F., & Heck, T. G. (2023) · Nutrition · doi:10.1016/j.nut.2023.112198 · Cited by 18
Mahmoudi-Aznaveh, A., Tavoosidana, G., Najmabadi, H., Azizi, Z., & Ardestani, A. D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1303930 · Cited by 18
Multi-omics analysis of Au@Pt nanozyme for the modulation of glucose and lipid metabolism
Wang, Y., Zhang, Q., Kan, M., Chang, F., He, X., Cheng, N., & Huang, K. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02807-8 · Cited by 18
Vaspin is a novel target gene of hepatic CCAAT-enhancer-binding protein
Aibara, D., Matsuo, K., Yamano, S., & Matsusue, K. (2019) · Gene · doi:10.1016/j.gene.2019.144113 · Cited by 17
Hexosaminidase A (HEXA) regulates hepatic sphingolipid and lipoprotein metabolism in mice
Montgomery, M. K., Taddese, A. Z., Bayliss, J., Nie, S., Williamson, N. A., & Watt, M. J. (2021) · The FASEB Journal · doi:10.1096/fj.202101186r · Cited by 17
Self-citationEmerging Links between Nonalcoholic Fatty Liver Disease and Neurodegeneration
Kelty, T. J., Dashek, R. J., Arnold, W. D., & Rector, R. S. (2023) · Seminars in Liver Disease · doi:10.1055/s-0043-1762585 · Cited by 19
Inflammation and Fibrosis in Progeria: Organ-Specific Responses in an HGPS Mouse Model
Krüger, P., Schroll, M., Fenzl, F. Q., Lederer, E.-M., Hartinger, R., Arnold, R., Togan, D. C., Guo, R., Liu, S., Petry, A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179323 · Cited by 17
Kiseleva, E. V., & Demidova, T. Y. (2021) · Obesity and metabolism · doi:10.14341/omet12758 · Cited by 17
Jin, L., Sun, Y., Li, Y., Zhang, H., Yu, W., Li, Y., Xin, Y., Alsareii, S. A., Wang, Q., & Zhang, D. (2021) · Peptides · doi:10.1016/j.peptides.2021.170597 · Cited by 17
Grilo, L. F., Diniz, M. S., Tocantins, C., Areia, A. L., & Pereira, S. P. (2022) · Obesities · doi:10.3390/obesities2030019 · Cited by 16
Cong, F., Zhu, L., Deng, L., Xue, Q., & Wang, J. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02708-4 · Cited by 17
Song, Q., Ling, Q., Fan, L., Deng, Y., Gao, Q., Yang, R., Chen, S., Wu, S., & Cai, J. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002111 · Cited by 17
Chen, Q., Jiang, F., Gao, X., Li, X., & Xia, P. (2023) · Liver International · doi:10.1111/liv.15654 · Cited by 16
Wang, Y., Wu, Y., Xu, M., Kulyar, M. F., Iqbal, M., Wu, J., Deng, X., Zhang, Y., Jiang, B., Hu, M., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126312 · Cited by 16
Chen, X., Peng, R., Peng, D., Xiao, J., Liu, D., & Li, R. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1282956 · Cited by 16
Alzahrani, A. Y., Gomha, S. M., Zaki, M. E. A., Farag, B., Abdelgawad, F. E., & Mohamed, M. A. (2024) · Future Medicinal Chemistry · doi:10.4155/fmc-2023-0351 · Cited by 16
The role of STAT3/VAV3 in glucolipid metabolism during the development of HFD-induced MAFLD
Jiang, Y., Luo, P., Cao, Y., Peng, D., Huo, S., Guo, J., Wang, M., Shi, W., Zhang, C., Li, S., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.86465 · Cited by 17
Gomha, S. M., El‐Ghany, N. A. A., Ebaid, M. S., Abolibda, T. Z., Zaki, M. E. A., Alhilal, M., Alhilal, S., & Mohamed, N. A. (2024) · Catalysts · doi:10.3390/catal14120840 · Cited by 16
Ling, S., Diao, H., Lu, G., & Shi, L. (2024) · BMC Public Health · doi:10.1186/s12889-024-20773-6 · Cited by 16
Pancreatic β-Cell Dysfunction Is Associated with Nonalcoholic Fatty Liver Disease
Chen, X., Xiao, J., Pang, J., Chen, S., Wang, Q., & Ling, W. (2021) · Nutrients · doi:10.3390/nu13093139 · Cited by 16
Ghodsian, N., Gagnon, É., Bourgault, J., Gobeil, É., Manikpurage, H. D., Perrot, N., Girard, A. S., Mitchell, P. L., & Arsenault, B. J. (2021) · Nutrients · doi:10.3390/nu13124208 · Cited by 14
Liu, X., Zhang, L.-Z., Zhang, H.-H., Lai, L.-F., Wang, Y.-Q., Sun, J., Xu, N.-G., & Li, Z.-X. (2022) · Acupuncture in Medicine · doi:10.1177/09645284211070301 · Cited by 15
Yin, G.-L., Liang, H.-Y., Sun, W.-X., Zhang, S.-Z., Feng, Y.-N., Liang, P., Chen, S.-T., Liu, X., Pan, W., & Zhang, F.-X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1016745 · Cited by 14
MicroRNA-34a Mediates High-Fat-Induced Hepatic Insulin Resistance by Targeting ENO3
Wang, Y., Zhao, X., Zhang, L., Yang, C., Zhang, K., Gu, Z., Ding, H., Li, S., Qin, J., & Chu, X. (2023) · Nutrients · doi:10.3390/nu15214616 · Cited by 15
Yi, M., Fasina, O. B., Li, Y., Xiang, L., & Qi, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316684 · Cited by 16
Zhang, J., Duan, M., Wu, S., Jiang, S., Hu, S., Chen, W., Zhang, J., Quan, H., Yang, W., & Wang, C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116955 · Cited by 15
Insulin induces expression of the hepatic vaspin gene
Aibara, D., Matsuo, K., Yamano, S., & Matsusue, K. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0276 · Cited by 15
Alén, R., García‐Martinez, I., Cobo‐Vuilleumier, N., Fernández‐Millán, E., Gallardo-Villanueva, P., Ferreira, V., Izquierdo, M., Moro, M. Á., Lizasoaín, I., Nieto, N., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06445-z · Cited by 14
Ge, M., Huang, L., Ma, Y.-J., Sun, S., Wu, L., Xu, W., & Yang, D. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112460 · Cited by 14
Hepatocyte Toll-Like Receptor 4 Mediates Alcohol-Induced Insulin Resistance in Mice
Wickramasinghe, P. B., Qian, S., Langley, L. E., Liu, C., & Jia, L. (2023) · Biomolecules · doi:10.3390/biom13030454 · Cited by 14
The essential effect of mTORC1-dependent lipophagy in non-alcoholic fatty liver disease
Tan, X., Huang, X., Lu, Z., Chen, L., Hu, J., Tian, X., & Qiu, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1124003 · Cited by 14
Hepatokines, bile acids and ketone bodies are novel Hormones regulating energy homeostasis
Garruti, G., Baj, J., Cignarelli, A., Perrini, S., & Giorgino, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1154561 · Cited by 15
Dai, L., Yuan, W., Jiang, R., Zhan, Z., Zhang, L., Xu, X., Qian, Y., Yang, W., & Zhang, Z. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-023-01988-9 · Cited by 14
Pal, H., Verma, P., & Mohanty, B. (2024) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.202300162 · Cited by 14
Zhang, D., Wang, Q., & Bai, F. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1410543 · Cited by 14
Yang, H., Ran, S., Zhou, Y., Shi, Q., Yu, J., Wang, W., Sun, C., Li, D., Hu, Y., Pan, C., et al. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c05671 · Cited by 14
Liver SMN restoration rescues the Smn mouse model of spinal muscular atrophy
Sutton, E. R., Beauvais, A., Yaworski, R., Repentigny, Y. D., Reilly, A., de Almeida, M. M. A., Deguise, M., Poulin, K. L., Parks, R. J., Schneider, B. L., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105444 · Cited by 15
Forouzesh, P., Kheirouri, S., & Alizadeh, M. (2025) · Scientific Reports · doi:10.1038/s41598-024-73132-1 · Cited by 14
Integrated liver-secreted and plasma proteomics identify a predictive model that stratifies MASH
Nardo, W. D., Lee, O., Johari, Y., Bayliss, J. A., Pensa, M., Miotto, P. M., Keenan, S. N., Ryan, A., Rucinski, A., Svinos, T. M., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102085 · Cited by 17
Self-citationCho, I. Y., Chang, Y., Kang, J., Kim, Y., Sung, E., Shin, H., Wild, S. H., Byrne, C. D., & Ryu, S. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac068 · Cited by 14
Tomita, Y., Misaka, T., Yoshihisa, A., Ichijo, Y., Ishibashi, S., Matsuda, M., Yamadera, Y., Ohara, H., Sugawara, Y., Hotsuki, Y., et al. (2022) · Clinical Research in Cardiology · doi:10.1007/s00392-022-02023-0 · Cited by 14
Wang, Y., Gao, X., Chen, X., Li, Q., Li, X., & Zhao, J. (2022) · Nutrients · doi:10.3390/nu14142903 · Cited by 14
Follistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent Pathway
Tong, J., Cong, L., Jia, Y., He, A. B.-L., Guo, Y., He, J., Li, D., Zou, B., & Li, J. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s380053 · Cited by 15
Yao, K., Zheng, H., & Peng, H. (2023) · Endokrynologia Polska · doi:10.5603/ep.93291 · Cited by 16
Imtiaz, A., Tahir, M. T. B., Zhao, M., Gong, D., Ge, J., & Geng, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178460 · Cited by 15
Chen, J., Wang, L., Zhou, Y., Zhao, S., Chen, Q., & Zheng, K. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100478 · Cited by 13
Li, J., Ma, Y., Qiu, T., Wang, J., Zhang, J., Sun, X., Jiang, L., Li, Q., & Yao, X. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116318 · Cited by 13
Roy, S., Saha, P., Bose, D., Trivedi, A., More, M., Lin, C., Wu, J., Oakes, M., & Chatterjee, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-60664-9 · Cited by 13
Rus, S. G., de la Foz, V. O., Arias, M., Iruzubieta, P., Gómez‐Revuelta, M., Juncal‐Ruíz, M., Crespo, J., Crespo‐Facorro, B., & Vázquez-Bourgón, J. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.06.001 · Cited by 13
Ordóñez-Vázquez, A. L., Juárez-Hernández, E., Zuarth-Vázquez, J. M., Ramos-Ostos, M. H., Uribe, M., Castro‐Narro, G., & López-Méndez, I. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912221 · Cited by 13
Six-Transmembrane Epithelial Antigen of Prostate 3 Promotes Hepatic Insulin Resistance and Steatosis
Ding, T., Chen, S., Xiao, W., Liu, Z., Tu, J., Yu, Y., Dong, B., Chen, W., & Zeng, Y. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100318 · Cited by 13
Yang, H., Mayneris‐Perxachs, J., Boqué, N., Bas-Prior, J. M. D., Arola, L., Yuan, M., Türkez, H., Uhlén, M., Borén, J., Zhang, C., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9101440 · Cited by 13
Magnesium deficiency in liver cirrhosis: a retrospective study
Peng, X., Xiang, R., Li, X., Tian, H., Li, C., Peng, Z., & Xiang, M. (2021) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2021.1888154 · Cited by 13
Wang, D., Wu, M., Zhang, X., Li, L., Lin, M., Shi, X., Zhao, Y., Huang, C., & Li, X. (2022) · Scientific Reports · doi:10.1038/s41598-022-17000-w · Cited by 12
From NAFLD to HCC: Advances in noninvasive diagnosis
Xu, Q., Feng, M., Ren, Y., Liu, X., Gao, H., Li, Z., Su, X., Wang, Q., & Wang, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115028 · Cited by 14
Wang, X., Wang, Z., Du, W., Ma, X., Ma, J., Chen, Z., Gao, C., & Chen, X. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237423 · Cited by 12
Wang, J., Bao, S., An, Q., Li, C., & Feng, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1544012 · Cited by 14
Macrophage-specific PHGDH protects against MAFLD by suppressing TAK1
Hu, P., Shan, X., Dong, H., Yu, S., Wang, B., Xiong, H., Ji, Z., Jing, W., Cui, Y., Li, Z., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115426 · Cited by 12
Aragón‐Herrera, A., Otero-Santiago, M., Anido‐Varela, L., Moraña‐Fernández, S., Campos‐Toimil, M., García‐Caballero, T., Barral, L., Tarazón, E., Roselló‐Lletí, E., Portolés, M., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.827033 · Cited by 12
Non-alcoholic fatty liver disease and liver secretome
Khan, M. S., Lee, C.-H., & Kim, S. G. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01419-w · Cited by 13
Liu, S., Liu, K., Wang, Y., Wu, C., Xiao, Y., Liu, S., Yu, J., Ma, Z., Liang, H., Li, X., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166620 · Cited by 12
Sheikhi, V., & Heidari, Z. (2022) · Advanced Biomedical Research · doi:10.4103/abr.abr_15_21 · Cited by 11
Asero, C., Giandalia, A., Cacciola, I., Morace, C., Lorello, G., Caspanello, A. R., Alibrandi, A., Squadrito, G., & Russo, G. T. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082858 · Cited by 11
Song, J., Zhou, D., Li, J., Wang, M., Jia, L., Lan, D., Song, H., Ji, X., & Meng, R. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14759 · Cited by 11
Chen, B.-T., Li, Z., Fang, J., Liu, Y., & Lin, A.-H. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106368 · Cited by 8
Yang, C., Zhang, H., Ma, Z., Fan, Y., Xu, Y., Tan, J., Tian, J., Cao, J., Zhang, W., Huang, G., et al. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.70029 · Cited by 11
A Mechanistic Rationale for Incretin-Based Therapeutics in the Management of Obesity
Samms, R. J., & Kusminski, C. M. (2024) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022724-105443 · Cited by 11
Ntikoudi, A., Papachristou, A., Tsalkitzi, A., Margari, N., Evangelou, E., & Vlachou, E. D. (2025) · Diabetology · doi:10.3390/diabetology6040023 · Cited by 14
Zhao, C., Lou, F., Li, X., Ma, J., Zhu, Z., Li, H., Zhai, Y., Chen, H., Zhang, Q., Liu, Z., et al. (2021) · PubMed Central · Cited by 11
Ghazanfar, H., Kandhi, S. D., Nawaz, I., Javed, N., Abraham, M. C., FARAG, M. E., Mahasamudram, J., Patel, V. B., Altaf, F., & Patel, H. (2021) · Cureus · doi:10.7759/cureus.15141 · Cited by 11
Zhang, Q., Zhang, L., Liu, K., Shang, H., Ruan, J., Yu, Z., Meng, S., Liang, F., Wang, T., Zhang, H., et al. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/1638740 · Cited by 11
Shao, C., Cheng, Q., Zhang, S., Xiang, X., & Xu, Y. (2022) · Annals of Palliative Medicine · doi:10.21037/apm-21-3890 · Cited by 11
Bashir, A., Duseja, A. K., Verma, A., De, A., & Tiwari, P. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.04.011 · Cited by 11
Abdelkader, C., Cherif, F. Z. H., Chenni, K., Eliuz, E. A. E., Pucci, L., & Yahia, D. A. (2022) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2022.27.1.78 · Cited by 11
Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma
Vachher, M., Bansal, S., Kumar, B., Yadav, S., Arora, T. K., Wali, N. M., & Burman, A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30252 · Cited by 11
Nucci, S. D., Castellana, F., Zupo, R., Lampignano, L., Chito, M. D., Rinaldi, R., Giannuzzi, V., Cozzolongo, R., Piazzolla, G., Giannelli, G., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1002669 · Cited by 11
Tong, Q., Gao, X., Lei, L., Zhang, W., Feng, J., Wang, X., Shen, Z., Liu, Z., Yi, H., Wu, S., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114903 · Cited by 11
Huangfu, G., Jaltotage, B., Pang, J., Lan, N. S. R., Abraham, A., Otto, J. H., Ihdayhid, A. R., Rankin, J. M., Chow, B. J. W., Watts, G. F., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155370 · Cited by 11
Hirata, A., Harada, S., Iida, M., Kurihara, A., Fukai, K., Kuwabara, K., Kato, S., Matsumoto, M., Sata, M., Miyagawa, N., et al. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64616 · Cited by 12
Roles of RNA m6A modification in nonalcoholic fatty liver disease
Tan, J., Wang, Y.-F., Dai, Z., Yin, H.-Z., Mu, C., Wang, S.-J., & Yang, F. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000046 · Cited by 10
Woerkom, A. V., Harney, D., Nagarajan, S. R., Hakeem-Sanni, M. F., Lin, J., Hooke, M., Pulpitel, T., Cooney, G. J., Larance, M., Saunders, D. N., et al. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00013.2024 · Cited by 15
Carciero, L., Giuseppe, G. D., Piazza, E. D., Parand, E., Soldovieri, L., Ciccarelli, G., Brunetti, M., Gasbarrini, A., Nista, E. C., Pani, G., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111837 · Cited by 11
Lu, X., Ma, R., Zhan, J., Pan, X., Liu, C., Shen, W., Zhang, S., Zhou, W., & Tian, Y. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.122795 · Cited by 10
Kalra, S., Bhattacharya, S., & Rawal, P. (2021) · Medical Sciences · doi:10.3390/medsci9020039 · Cited by 11
Sarcopenia in the setting of nonalcoholic fatty liver
Arrese, M. A., Cabello‐Verrugio, C., Arab, J. P., Francisco Barrera, M., Baudrand, R. F., Guarda, F. J., Gul, I., & Cabrera, D. (2022) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2021.16 · Cited by 10
Chen, L., Lv, X., Kan, M., Wang, R., Wang, H., & Zang, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012464 · Cited by 11
Metadata
- Authors
- Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K.
- Affiliations
- The University of Melbourne (AU)
- Department of Physiology, University of Melbourne, Melbourne, Victoria, Australia
- Corresponding author
- Watt, Matthew J
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2019-04-25
- Volume
- 40
- Issue
- 5
- Pages
- 1367-1393
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2942227779
- Cited by
- 615
- References
- 385
- Citations by year
- 2026: 61 · 2025: 98 · 2024: 109 · 2023: 98 · 2022: 128 · 2021: 83 · 2020: 31 · 2019: 7
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Health and Medical Research Council (APP1077703, APP1143224, APP1162511, APP1156508)
- Natural Sciences and Engineering Research Council of Canada
- Melbourne Research Scholarship, University of Melbourne (AU)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- non-alcoholic fatty liver disease, insulin resistance, hepatokines, hepatic lipid metabolism, microRNA, extracellular vesicles, exosomes, type 2 diabetes, muscle metabolism, adipose tissue, pancreas
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Endocrine Glands, Humans, Insulin Resistance, Liver, Dyslipidemias, Lipid Metabolism, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
